The genomics and biotechnology company has launched a comprehensive genetic study in an effort to discover why COVID-19 elicits such an acute response in some patients but not in others.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,